The FDA required a label change for Lunesta after it was associated with psychomotor and memory impairment. This adverse side effect could put people on the medication who drive to work the next day at risk.
The FDA required a label change for Lunesta after it was associated with psychomotor and memory impairment. This adverse side effect could put people on the medication who drive to work the next day at risk.